BIOMAT Database Logo BIOMAT Database Logo

Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma. 2019

Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
Department of Hematology, PL General Hospital, 2204, Shindo, Tondabayashi, Osaka, 584-8585, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D003520 Cyclophosphamide Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer. (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate,B-518,Cyclophosphamide Anhydrous,Cyclophosphamide Monohydrate,Cyclophosphamide, (R)-Isomer,Cyclophosphamide, (S)-Isomer,Cyclophosphane,Cytophosphan,Cytophosphane,Cytoxan,Endoxan,NSC-26271,Neosar,Procytox,Sendoxan,B 518,B518,NSC 26271,NSC26271
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections
D013212 Staphylococcus epidermidis A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.

Related Publications

Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
Cytotoxic T-lymphocyte-associated antigen-4.
July 2011, Clinical cancer research : an official journal of the American Association for Cancer Research,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
Cytotoxic T-lymphocyte-associated antigen-4.
September 2007, Clinical cancer research : an official journal of the American Association for Cancer Research,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
Anti-ATLA (antibody to adult T-cell leukemia-lymphoma virus-associated antigen)-negative adult T-cell leukemia-lymphoma.
January 1983, Japanese journal of clinical oncology,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
Adult T-cell leukemia/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells.
January 2008, Cancer science,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
[Adult T-cell leukemia/lymphoma associated with unusual positivity of anti-ATLA (adult T-cell leukemia-cell-associated antigen) antibodies].
March 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
Cytotoxic T lymphocyte-associated antigen-4 inhibits integrin-mediated stimulation.
October 2002, Immunology,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma.
January 2017, Neoplasma,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
T-cell associated antigen-positive B-cell lymphoma.
January 2001, Leukemia & lymphoma,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
[Aggressive NK/T cell leukemia/lymphoma associated with EBV].
December 2011, Acta medica portuguesa,
Sanae Sueda, and Shoko Nakayama, and Tatsuya Adachi, and Yuka Ohashi, and Sumie Awaji, and Shigeo Hashimoto, and Itaru Matsumura, and Mitsuhiro Matsuda
Development of adult T-cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen-positive healthy adults.
October 1982, Gan,
Copied contents to your clipboard!